161 related articles for article (PubMed ID: 10582662)
1. In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.
Verstappen CC; Geldof AA; Postma TJ; Heimans JJ
J Neurooncol; 1999 Aug; 44(1):1-5. PubMed ID: 10582662
[TBL] [Abstract][Full Text] [Related]
2. Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.
Verstappen CC; Postma TJ; Geldof AA; Heimans JJ
Anticancer Res; 2004; 24(4):2337-41. PubMed ID: 15330181
[TBL] [Abstract][Full Text] [Related]
3. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells.
Mendonça LM; da Silva Machado C; Teixeira CC; de Freitas LA; Bianchi Mde L; Antunes LM
Neurotoxicology; 2013 Jan; 34():205-11. PubMed ID: 23036615
[TBL] [Abstract][Full Text] [Related]
4. Cytostatic activity of cisplatin in the presence of WR2721 and its thiol metabolite WR1065 in OVCAR-3 human ovarian cancer cells as compared to V79 fibroblasts.
Treskes M; Nijtmans L; Fichtinger-Schepman AM; van der Vijgh WJ
Anticancer Res; 1992; 12(6B):2261-5. PubMed ID: 1338281
[TBL] [Abstract][Full Text] [Related]
5. Phenoxodiol protects against Cisplatin induced neurite toxicity in a PC-12 cell model.
Klein R; Brown D; Turnley AM
BMC Neurosci; 2007 Aug; 8():61. PubMed ID: 17672914
[TBL] [Abstract][Full Text] [Related]
6. Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B.
Ceresa C; Avan A; Giovannetti E; Geldof AA; Avan A; Cavaletti G; Peters GJ
Anticancer Res; 2014 Jan; 34(1):517-23. PubMed ID: 24403510
[TBL] [Abstract][Full Text] [Related]
7. Nerve-growth-factor-dependent neurite outgrowth assay; a research model for chemotherapy-induced neuropathy.
Geldof AA
J Cancer Res Clin Oncol; 1995; 121(11):657-60. PubMed ID: 7593129
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Role of Selected Antioxidant Agents in Preventing Cisplatin-Induced Damage of Human Neurons In Vitro.
Popović J; Klajn A; Paunesku T; Ma Q; Chen S; Lai B; Stevanović M; Woloschak GE
Cell Mol Neurobiol; 2019 Jul; 39(5):619-636. PubMed ID: 30874981
[TBL] [Abstract][Full Text] [Related]
9. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
Treskes M; Nijtmans LG; Fichtinger-Schepman AM; van der Vijgh WJ
Biochem Pharmacol; 1992 Mar; 43(5):1013-9. PubMed ID: 1313234
[TBL] [Abstract][Full Text] [Related]
10. Ameliorative effects of aqueous extract of Forsythiae suspensa fruits on oxaliplatin-induced neurotoxicity in vitro and in vivo.
Yi JM; Shin S; Kim NS; Bang OS
BMC Complement Altern Med; 2019 Nov; 19(1):339. PubMed ID: 31783843
[TBL] [Abstract][Full Text] [Related]
11. Use of C. elegans as a 3R-compliant in vivo model for the chemoprevention of cisplatin-induced neurotoxicity.
Wellenberg A; Weides L; Kurzke J; Hennecke T; Bornhorst J; Crone B; Karst U; Brinkmann V; Fritz G; Honnen S
Exp Neurol; 2021 Jul; 341():113705. PubMed ID: 33753139
[TBL] [Abstract][Full Text] [Related]
12. NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants.
Hayakawa K; Itoh T; Niwa H; Mutoh T; Sobue G
Brain Res; 1998 Jun; 794(2):313-9. PubMed ID: 9622663
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor prevention of aged-rat sympathetic neuron injury by cisplatin, vincristine and taxol--in vitro explant study.
Hayakawa K; Itoh T; Niwa H; Yamamoto M; Liang Y; Doyu M; Sobue G
Neurosci Lett; 1999 Oct; 274(2):103-6. PubMed ID: 10553948
[TBL] [Abstract][Full Text] [Related]
14. Caffeic Acid Phenethyl Ester (CAPE) Protects PC12 Cells from Cisplatin-Induced Neurotoxicity by Activating the NGF-Signaling Pathway.
Ferreira RS; Dos Santos NAG; Martins NM; Fernandes LS; Dos Santos AC
Neurotox Res; 2018 Jul; 34(1):32-46. PubMed ID: 29260495
[TBL] [Abstract][Full Text] [Related]
15. The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278.
Treskes M; Holwerda U; Nijtmans LG; Pinedo HM; van der Vijgh WJ
Cancer Chemother Pharmacol; 1992; 29(6):467-70. PubMed ID: 1314713
[TBL] [Abstract][Full Text] [Related]
16. Vinca-alkaloid neurotoxicity measured using an in vitro model.
Geldof AA; Minneboo A; Heimans JJ
J Neurooncol; 1998 Apr; 37(2):109-13. PubMed ID: 9524088
[TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q10 protects Pc12 cells from cisplatin-induced DNA damage and neurotoxicity.
da Silva Machado C; Mendonça LM; Venancio VP; Bianchi ML; Antunes LM
Neurotoxicology; 2013 May; 36():10-6. PubMed ID: 23434506
[TBL] [Abstract][Full Text] [Related]
18. Caffeic Acid Phenethyl Ester (CAPE) Protects PC12 Cells Against Cisplatin-Induced Neurotoxicity by Activating the AMPK/SIRT1, MAPK/Erk, and PI3k/Akt Signaling Pathways.
Ferreira RS; Dos Santos NAG; Bernardes CP; Sisti FM; Amaral L; Fontana ACK; Dos Santos AC
Neurotox Res; 2019 Jul; 36(1):175-192. PubMed ID: 31016689
[TBL] [Abstract][Full Text] [Related]
19. Non-cytotoxic Concentration of Cisplatin Decreases Neuroplasticity-Related Proteins and Neurite Outgrowth Without Affecting the Expression of NGF in PC12 Cells.
Ferreira RS; Dos Santos NA; Martins NM; Fernandes LS; Dos Santos AC
Neurochem Res; 2016 Nov; 41(11):2993-3003. PubMed ID: 27473385
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone prevents cisplatin neurotoxicity in primary DRG neurons.
Üstün R; Oğuz EK; Şeker A; Korkaya H
Neurotoxicology; 2018 Dec; 69():68-76. PubMed ID: 30227172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
